Retraction
Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines
Paper Information
Record ID:
3942
Journal:
Publication Date:
July 24, 2007
Retraction Date:
June 30, 2015
(10.4 years years ago)
Subjects:
Institution:
Department of Oncology, Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New YorkCountry:
🇺🇸 United StatesArticle Type:
Publisher:
ASPET: American Society for Pharmacology and Experimental Therapeutics
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (70)
70
Total Citations15
Post-Retraction(21.4%)
48
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
9
After 2+ years
3396
Days since retraction (latest)
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2024
3396 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2022
2663 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Sep 2022
2628 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2022
2509 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jul 2021
2223 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2021
2141 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Aug 2020
1859 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Mar 2018
980 days after retraction
Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform
Yashar Mesbahi, Ali Zekri, Shahin Ahmadian et al. (6 authors)
European Journal of Pharmacology
Published: Dec 2017
22 citations
22 citations
904 days after retraction
Paper citing Oncogenic role of the ubiquitin ligase subunit Skp...
Unknown Authors
Unknown Journal
Published: May 2017
687 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2016
540 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2016
468 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2016
306 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2015
163 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Sep 2015
70 days after retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Apr 2015
82 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2014
211 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2014
211 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Sep 2014
286 days before retraction
Neuroprotective effects of the anti‐cancer drug sunitinib in models of <scp>HIV</scp> neurotoxicity suggests potential for the treatment of neurodegenerative disorders
Wolf Wrasidlo, Leslie Crews, Igor F. Tsigelny et al. (12 authors)
British Journal of Pharmacology
Open Access
Published: Aug 2014
26 citations
26 citations
321 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2014
400 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jan 2014
539 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jan 2014
545 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2013
576 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2013
635 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Sep 2013
667 days before retraction
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib
Yiyu Zou, Yi‐He Ling, Juan Sironi et al. (6 authors)
Journal of Thoracic Oncology
Open Access
Published: Apr 2013
120 citations
120 citations
810 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Feb 2013
879 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jan 2013
892 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2012
1002 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Aug 2012
1052 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jul 2012
1086 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jun 2012
1124 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2011
1307 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2011
1345 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2011
1355 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Oct 2011
1368 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Sep 2011
1370 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jul 2011
1453 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jun 2011
1490 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2011
1491 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Mar 2011
1582 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2010
1876 days before retraction
Quick Stats
Total Citations:
70
Years Since Retraction:
10.4 years
Open Access:
Yes
Last Checked:
Never